Inh: Clinical Trials

6 trials of Inh, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 withdrawn. 6 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Completed 5, Withdrawn 1
Phase 21Completed 1

Follow Inh: new trials by email Literature Review of Inh trials Research Report on Inh

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
1HP Versus 3HR in the Treatment of Tuberculosis Infection in Vietnam
Isoniazid, Rifapentine, Rifampicin - Tuberculosis Infection
Phase 3WithdrawnFreundeskreis Für Internationale Tuberkulosehilfe e.V2024-11-012026-09-09
Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care
Bedaquiline Oral Tablet, Linezolid Oral Tablet, Delamanid in Oral Dosage Form - Tuberculosis, Pre-XDR-TB
Phase 3CompletedWits Health Consortium (Pty) Ltd4022019-08-222024-08-28
An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis
Linezolid, Bedaquiline, Levofloxacin - Tuberculosis, Multidrug Resistant Tuberculosis
Phase 2 / Phase 3CompletedUniversity of Cape Town1542015-11-122021-09-29
Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention
Weekly INH / RRT given by DOT - Silicosis, Tuberculosis
Phase 3CompletedHuashan Hospital5662015-03-012020-06-30
Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
Self Administered Therapy (SAT), SMS reminders, isoniazid and rifapentine - Latent Tuberculosis Infection
Phase 3CompletedCenters for Disease Control and Prevention10022012-09-012025-03-13
Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection
RPT + INH once weekly for 3 months given by DOT, Isoniazid (INH) daily for 9 months - Tuberculosis
Phase 3CompletedCenters for Disease Control and Prevention80532001-06-012024-08-27

Conditions studied

Tuberculosis (5)  ·  Extensively Drug-Resistant Tuberculosis (2)  ·  Latent Tuberculosis (2)  ·  Tuberculosis, Multidrug-Resistant (2)  ·  Silicosis (1)

Sponsors

Centers for Disease Control and Prevention (2)  ·  Freundeskreis Für Internationale Tuberkulosehilfe e.V (1)  ·  Huashan Hospital (1)  ·  University of Cape Town (1)  ·  Wits Health Consortium (Pty) Ltd (1)

Countries

South Africa (3)  ·  China (2)  ·  Spain (2)  ·  United States (2)  ·  Brazil (1)  ·  Canada (1)  ·  Vietnam (1)

Top investigators

Andrey S Borisov, MD, MPH (1)  ·  Elsa M Villarino, MD, MPH (1)  ·  Francesca M Conradie (1)  ·  Keertan Dheda, MBChB (1)  ·  Robert Belknap, MD (1)  ·  Timothy Sterling, MD (1)  ·  Wenhong Zhang, MD,PhD (1)

Results publications

PMID 29393655, PMID 22150035, PMID 25580725, PMID 25904367, PMID 26951571, PMID 27243774, PMID 28087928, PMID 29114781, PMID 31690107, PMID 31770617, PMID 31932382, PMID 32553881, PMID 34042560, PMID 35175905, PMID 36815322, PMID 38640958, PMID 40320069, PMID 42341301